Redica Systems

Warning Letters 2016 – Data Governance & Data Integrity

May 3, 2017

Why is No One Talking About This? 2016 was the Year the FDA Exploded on China

April 17, 2017

Delay, Denial, or Limiting of Inspections Since 2008

April 12, 2017

Assessing Your Readiness State for FSMA: Stabilize, Then Benchmark

March 13, 2017

The Story of 3 Consent Decrees

August 25, 2016

EU vs. FDA: My Inspectors are More Rigorous Than Yours

August 11, 2016

5 Features to Look for in an EIR

August 5, 2016

To Understand Data Integrity, Just Read These 6 FDA 483s

July 21, 2016

Welcome to the new FDAzilla.com

July 7, 2016

5 FEATURES TO LOOK FOR IN A WARNING LETTER

June 30, 2016

Does an FDA Import Alert automatically equate to an impending FDA Warning Letter?

April 30, 2016

Data Integrity and Enforcement Actions

February 8, 2016

Data Integrity: The Whole Story

April 9, 2015

4 Trends About GMP Inspection Readiness and FDA Data Intelligence

February 25, 2015

Everything you’ve ever wanted to know about how FDA 483s are written

August 23, 2013

8 Key cGMP Areas FDA Inspectors Seem to Focus On

August 13, 2013

Dinner in Costa Rica with an FDA inspector (and his wife)

August 10, 2013

Seven Success Criteria for Hiring (and working with) a Good GMP Consultant

June 21, 2012